

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phenol-containing compound catabolic process (GO:0019336) | 8.82292581 |
| 2 | dopamine biosynthetic process (GO:0042416) | 6.31357655 |
| 3 | neurotransmitter catabolic process (GO:0042135) | 5.67012711 |
| 4 | catecholamine transport (GO:0051937) | 5.54589061 |
| 5 | dopamine transport (GO:0015872) | 5.34231003 |
| 6 | catechol-containing compound biosynthetic process (GO:0009713) | 5.10527025 |
| 7 | catecholamine biosynthetic process (GO:0042423) | 5.10527025 |
| 8 | behavioral response to nicotine (GO:0035095) | 5.04890893 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.73512992 |
| 10 | alkaloid metabolic process (GO:0009820) | 4.66916271 |
| 11 | mating behavior (GO:0007617) | 4.65724406 |
| 12 | dopamine metabolic process (GO:0042417) | 4.64429830 |
| 13 | behavioral response to ethanol (GO:0048149) | 4.61181453 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56187686 |
| 15 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.47656086 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.46379252 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 4.44652830 |
| 18 | vocalization behavior (GO:0071625) | 4.27228993 |
| 19 | neurotransmitter biosynthetic process (GO:0042136) | 4.23337177 |
| 20 | regulation of dopamine metabolic process (GO:0042053) | 4.20008955 |
| 21 | regulation of catecholamine metabolic process (GO:0042069) | 4.20008955 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.09808484 |
| 23 | synaptic transmission, cholinergic (GO:0007271) | 4.00489332 |
| 24 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.95684773 |
| 25 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.91364413 |
| 26 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.86449205 |
| 27 | neurotransmitter transport (GO:0006836) | 3.85025264 |
| 28 | negative regulation of microtubule polymerization (GO:0031115) | 3.70873427 |
| 29 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.68497072 |
| 30 | glutamate secretion (GO:0014047) | 3.66685756 |
| 31 | ATP synthesis coupled proton transport (GO:0015986) | 3.66216913 |
| 32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.66216913 |
| 33 | regulation of neurotransmitter levels (GO:0001505) | 3.65164531 |
| 34 | proline transport (GO:0015824) | 3.59537140 |
| 35 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.57999377 |
| 36 | sympathetic nervous system development (GO:0048485) | 3.57592793 |
| 37 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.54037018 |
| 38 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.51612306 |
| 39 | neurotransmitter metabolic process (GO:0042133) | 3.51507193 |
| 40 | response to insecticide (GO:0017085) | 3.50739748 |
| 41 | regulation of vesicle fusion (GO:0031338) | 3.50120575 |
| 42 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.42738252 |
| 43 | prepulse inhibition (GO:0060134) | 3.41160700 |
| 44 | neuromuscular synaptic transmission (GO:0007274) | 3.38894951 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.37897210 |
| 46 | neuronal action potential propagation (GO:0019227) | 3.37050434 |
| 47 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.35553391 |
| 48 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.30351247 |
| 49 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.30351247 |
| 50 | monoamine transport (GO:0015844) | 3.28455929 |
| 51 | catecholamine metabolic process (GO:0006584) | 3.24786470 |
| 52 | catechol-containing compound metabolic process (GO:0009712) | 3.24786470 |
| 53 | electron transport chain (GO:0022900) | 3.24159881 |
| 54 | neuron recognition (GO:0008038) | 3.23817561 |
| 55 | detection of calcium ion (GO:0005513) | 3.23042544 |
| 56 | regulation of protein kinase A signaling (GO:0010738) | 3.22313558 |
| 57 | phenol-containing compound biosynthetic process (GO:0046189) | 3.20981925 |
| 58 | response to amphetamine (GO:0001975) | 3.20847536 |
| 59 | cell differentiation in hindbrain (GO:0021533) | 3.20610178 |
| 60 | respiratory electron transport chain (GO:0022904) | 3.19569127 |
| 61 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.18588844 |
| 62 | neuron-neuron synaptic transmission (GO:0007270) | 3.17212746 |
| 63 | synaptic transmission, dopaminergic (GO:0001963) | 3.17028885 |
| 64 | response to cocaine (GO:0042220) | 3.16138430 |
| 65 | protein localization to synapse (GO:0035418) | 3.14360880 |
| 66 | regulation of neurotransmitter transport (GO:0051588) | 3.11471986 |
| 67 | synaptic vesicle maturation (GO:0016188) | 3.10232180 |
| 68 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.09052017 |
| 69 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.08091251 |
| 70 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07919571 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 3.07492524 |
| 72 | negative regulation of hormone metabolic process (GO:0032351) | 3.06164745 |
| 73 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04938490 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.04535366 |
| 75 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.04407563 |
| 76 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.04407563 |
| 77 | glutamate receptor signaling pathway (GO:0007215) | 3.04340784 |
| 78 | maternal behavior (GO:0042711) | 3.04289666 |
| 79 | negative regulation of neurotransmitter transport (GO:0051589) | 3.04035435 |
| 80 | locomotory exploration behavior (GO:0035641) | 3.03835918 |
| 81 | response to histamine (GO:0034776) | 3.01631777 |
| 82 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.01225209 |
| 83 | regulation of synaptic vesicle transport (GO:1902803) | 3.00670357 |
| 84 | norepinephrine metabolic process (GO:0042415) | 3.00576146 |
| 85 | synapse assembly (GO:0007416) | 2.99788938 |
| 86 | cerebellar granule cell differentiation (GO:0021707) | 2.99151887 |
| 87 | regulation of dopamine secretion (GO:0014059) | 2.97710387 |
| 88 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.95891569 |
| 89 | axonal fasciculation (GO:0007413) | 2.93598279 |
| 90 | behavioral response to cocaine (GO:0048148) | 2.93544227 |
| 91 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.92919402 |
| 92 | toxin metabolic process (GO:0009404) | 2.92847204 |
| 93 | positive regulation of synapse assembly (GO:0051965) | 2.92464099 |
| 94 | striatum development (GO:0021756) | 2.91851674 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 2.91518850 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.91025038 |
| 97 | regulation of respiratory gaseous exchange (GO:0043576) | 2.90983061 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90744424 |
| 99 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.90459001 |
| 100 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.89702051 |
| 101 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.89280940 |
| 102 | neuron remodeling (GO:0016322) | 2.89260835 |
| 103 | layer formation in cerebral cortex (GO:0021819) | 2.88978005 |
| 104 | transmission of nerve impulse (GO:0019226) | 2.88901768 |
| 105 | regulation of cell communication by electrical coupling (GO:0010649) | 2.88677686 |
| 106 | inner ear receptor cell development (GO:0060119) | 2.86531088 |
| 107 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.76962811 |
| 108 | positive regulation of protein autophosphorylation (GO:0031954) | 2.71261932 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.70210257 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.54435954 |
| 111 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.52680446 |
| 112 | urinary tract smooth muscle contraction (GO:0014848) | 2.51774626 |
| 113 | cellular potassium ion homeostasis (GO:0030007) | 2.49564224 |
| 114 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.46942515 |
| 115 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.44494649 |
| 116 | auditory behavior (GO:0031223) | 2.37747139 |
| 117 | presynaptic membrane organization (GO:0097090) | 2.32780823 |
| 118 | kidney mesenchyme development (GO:0072074) | 2.30796369 |
| 119 | endocardial cushion development (GO:0003197) | 2.27936077 |
| 120 | apical protein localization (GO:0045176) | 2.27270580 |
| 121 | chemosensory behavior (GO:0007635) | 2.25343141 |
| 122 | regulation of axon guidance (GO:1902667) | 2.24260125 |
| 123 | smooth muscle tissue development (GO:0048745) | 2.24117258 |
| 124 | regulation of synapse assembly (GO:0051963) | 2.21397346 |
| 125 | cilium movement (GO:0003341) | 2.21023294 |
| 126 | metanephric mesenchyme development (GO:0072075) | 2.20447678 |
| 127 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.17607109 |
| 128 | cellular response to vitamin D (GO:0071305) | 2.17472194 |
| 129 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.15816935 |
| 130 | negative regulation of axon guidance (GO:1902668) | 2.15225912 |
| 131 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.15173863 |
| 132 | neuronal action potential (GO:0019228) | 2.15005326 |
| 133 | righting reflex (GO:0060013) | 2.13958329 |
| 134 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.13355159 |
| 135 | presynaptic membrane assembly (GO:0097105) | 2.12851680 |
| 136 | myoblast fusion (GO:0007520) | 2.12656960 |
| 137 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.11584157 |
| 138 | innervation (GO:0060384) | 2.11149986 |
| 139 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.11000467 |
| 140 | insulin secretion (GO:0030073) | 2.10781517 |
| 141 | response to gravity (GO:0009629) | 2.09051465 |
| 142 | negative regulation of dendrite development (GO:2000171) | 2.08704636 |
| 143 | membrane depolarization during action potential (GO:0086010) | 2.07994723 |
| 144 | epithelial cilium movement (GO:0003351) | 2.06858446 |
| 145 | metanephric tubule development (GO:0072170) | 2.05706272 |
| 146 | metanephric nephron tubule development (GO:0072234) | 2.05706272 |
| 147 | auditory receptor cell differentiation (GO:0042491) | 2.05479821 |
| 148 | multicellular organismal signaling (GO:0035637) | 2.04839970 |
| 149 | artery development (GO:0060840) | 2.03436077 |
| 150 | cardiac conduction (GO:0061337) | 2.03080681 |
| 151 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.01961417 |
| 152 | cellular response to vitamin (GO:0071295) | 2.00952525 |
| 153 | cranial nerve morphogenesis (GO:0021602) | 2.00570917 |
| 154 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.00033348 |
| 155 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.98562176 |
| 156 | retina layer formation (GO:0010842) | 1.97680186 |
| 157 | negative regulation of gluconeogenesis (GO:0045721) | 1.96224555 |
| 158 | axonemal dynein complex assembly (GO:0070286) | 1.96127224 |
| 159 | potassium ion homeostasis (GO:0055075) | 1.94934661 |
| 160 | actin filament depolymerization (GO:0030042) | 1.94930131 |
| 161 | left/right pattern formation (GO:0060972) | 1.94763419 |
| 162 | gamma-aminobutyric acid transport (GO:0015812) | 1.94745804 |
| 163 | action potential (GO:0001508) | 1.94472611 |
| 164 | establishment of protein localization to Golgi (GO:0072600) | 1.94376057 |
| 165 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 1.94368415 |
| 166 | regulation of action potential (GO:0098900) | 1.93146435 |
| 167 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.92766611 |
| 168 | synaptic transmission, glutamatergic (GO:0035249) | 1.92523423 |
| 169 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.92156048 |
| 170 | tonic smooth muscle contraction (GO:0014820) | 1.92030555 |
| 171 | negative regulation of neurotransmitter secretion (GO:0046929) | 1.91930485 |
| 172 | regulation of respiratory system process (GO:0044065) | 1.91715754 |
| 173 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 1.91061961 |
| 174 | cell communication involved in cardiac conduction (GO:0086065) | 1.91036219 |
| 175 | protein targeting to Golgi (GO:0000042) | 1.90992852 |
| 176 | vascular smooth muscle contraction (GO:0014829) | 1.90433370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.94596422 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61971561 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.29606949 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08890835 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08115671 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73201704 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58149810 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53142215 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51139298 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51139298 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42563664 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41328688 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38980334 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32163010 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.30630025 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.23318429 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.21130490 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19701056 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.19637168 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.11906134 |
| 21 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.08403528 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.08089263 |
| 23 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.00735650 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.00053703 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96206880 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94849664 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92761804 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91953793 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.87526043 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85084972 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85074290 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83294302 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83127624 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81651821 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81067010 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80096370 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79466325 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79328592 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78261849 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77448296 |
| 41 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72821769 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70966690 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68671222 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.67824090 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62867077 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56228080 |
| 47 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53801400 |
| 48 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48658640 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48289944 |
| 50 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47031429 |
| 51 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44040164 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43865581 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42974925 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42511610 |
| 55 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.42090474 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41351341 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37287643 |
| 58 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.37121439 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37075536 |
| 60 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36730002 |
| 61 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36484789 |
| 62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.35886521 |
| 63 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33452330 |
| 64 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31947713 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30321221 |
| 66 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27531704 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26710195 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26324403 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26324403 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25341764 |
| 71 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24593043 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23933760 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23928082 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23749700 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23571485 |
| 76 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20678236 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18944482 |
| 78 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18554840 |
| 79 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18071706 |
| 80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17468468 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14336145 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13698229 |
| 83 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.11418209 |
| 84 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09992342 |
| 85 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09968680 |
| 86 | JUN_21703547_ChIP-Seq_K562_Human | 1.08057708 |
| 87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08029293 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07510490 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07025451 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06785462 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06661398 |
| 92 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06496613 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05747896 |
| 94 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.05399364 |
| 95 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.04222820 |
| 96 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04153542 |
| 97 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03551940 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03160013 |
| 99 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02656224 |
| 100 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02430856 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01892474 |
| 102 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01555889 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01364677 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99540890 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98822342 |
| 106 | AR_19668381_ChIP-Seq_PC3_Human | 0.96973120 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94484094 |
| 108 | * EWS_26573619_Chip-Seq_HEK293_Human | 0.93022863 |
| 109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91686538 |
| 110 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91401876 |
| 111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90896941 |
| 112 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90896941 |
| 113 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.90599915 |
| 114 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89475328 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89381035 |
| 116 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89253699 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88959172 |
| 118 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87909434 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87730080 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.87661733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 5.38917735 |
| 2 | MP0003880_abnormal_central_pattern | 4.01718949 |
| 3 | MP0001905_abnormal_dopamine_level | 3.35445773 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.33460359 |
| 5 | MP0009046_muscle_twitch | 3.25386559 |
| 6 | MP0001529_abnormal_vocalization | 3.23587098 |
| 7 | * MP0003635_abnormal_synaptic_transmissio | 3.07248931 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 3.04052977 |
| 9 | MP0009745_abnormal_behavioral_response | 3.03225798 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.95951705 |
| 11 | MP0003283_abnormal_digestive_organ | 2.89118903 |
| 12 | MP0002064_seizures | 2.72759075 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.70223254 |
| 14 | MP0004270_analgesia | 2.67369282 |
| 15 | MP0001440_abnormal_grooming_behavior | 2.66149283 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.54766597 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.43355067 |
| 18 | MP0002638_abnormal_pupillary_reflex | 2.42132744 |
| 19 | MP0004924_abnormal_behavior | 2.38692176 |
| 20 | MP0005386_behavior/neurological_phenoty | 2.38692176 |
| 21 | MP0002272_abnormal_nervous_system | 2.35326787 |
| 22 | MP0002063_abnormal_learning/memory/cond | 2.32399910 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.30802714 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.28348506 |
| 25 | MP0002733_abnormal_thermal_nociception | 2.19520151 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.18470993 |
| 27 | MP0001970_abnormal_pain_threshold | 2.10225086 |
| 28 | MP0002067_abnormal_sensory_capabilities | 2.04293896 |
| 29 | MP0003122_maternal_imprinting | 1.87613670 |
| 30 | MP0001486_abnormal_startle_reflex | 1.87008859 |
| 31 | MP0003123_paternal_imprinting | 1.81811444 |
| 32 | MP0008872_abnormal_physiological_respon | 1.80243597 |
| 33 | MP0001188_hyperpigmentation | 1.77301664 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.71742685 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.66841240 |
| 36 | MP0008569_lethality_at_weaning | 1.65477901 |
| 37 | MP0002736_abnormal_nociception_after | 1.63721577 |
| 38 | * MP0002184_abnormal_innervation | 1.61640078 |
| 39 | MP0001984_abnormal_olfaction | 1.58228310 |
| 40 | MP0000751_myopathy | 1.51426935 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.50112355 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.48940691 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.48141260 |
| 44 | MP0000538_abnormal_urinary_bladder | 1.45434782 |
| 45 | MP0000778_abnormal_nervous_system | 1.40043568 |
| 46 | MP0004142_abnormal_muscle_tone | 1.38244002 |
| 47 | MP0000534_abnormal_ureter_morphology | 1.34434107 |
| 48 | MP0005409_darkened_coat_color | 1.34300433 |
| 49 | MP0000462_abnormal_digestive_system | 1.32968366 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.32719224 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.31115867 |
| 52 | MP0002102_abnormal_ear_morphology | 1.28589525 |
| 53 | MP0003942_abnormal_urinary_system | 1.26389678 |
| 54 | MP0004858_abnormal_nervous_system | 1.25350366 |
| 55 | MP0004133_heterotaxia | 1.25030944 |
| 56 | MP0009379_abnormal_foot_pigmentation | 1.21536690 |
| 57 | * MP0002066_abnormal_motor_capabilities/c | 1.20832542 |
| 58 | MP0005535_abnormal_body_temperature | 1.18070041 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.17528921 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.17049052 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.16899825 |
| 62 | MP0000955_abnormal_spinal_cord | 1.16517803 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.16002015 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.14794956 |
| 65 | MP0004043_abnormal_pH_regulation | 1.14327290 |
| 66 | MP0002234_abnormal_pharynx_morphology | 1.12989044 |
| 67 | MP0000427_abnormal_hair_cycle | 1.12975855 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.12711012 |
| 69 | MP0002751_abnormal_autonomic_nervous | 1.12291173 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.11144092 |
| 71 | MP0003279_aneurysm | 1.11082385 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.10286144 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.10255992 |
| 74 | MP0000569_abnormal_digit_pigmentation | 1.09709434 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.08926724 |
| 76 | MP0003937_abnormal_limbs/digits/tail_de | 1.07564312 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.05443706 |
| 78 | MP0002160_abnormal_reproductive_system | 1.04515688 |
| 79 | MP0004134_abnormal_chest_morphology | 1.04371077 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.04206158 |
| 81 | MP0005499_abnormal_olfactory_system | 1.01869605 |
| 82 | MP0005394_taste/olfaction_phenotype | 1.01869605 |
| 83 | MP0004742_abnormal_vestibular_system | 1.00086887 |
| 84 | MP0004085_abnormal_heartbeat | 0.99456622 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.98674948 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.98279830 |
| 87 | MP0002108_abnormal_muscle_morphology | 0.97751608 |
| 88 | MP0003329_amyloid_beta_deposits | 0.97732105 |
| 89 | MP0001944_abnormal_pancreas_morphology | 0.96604347 |
| 90 | MP0003890_abnormal_embryonic-extraembry | 0.96354575 |
| 91 | * MP0005551_abnormal_eye_electrophysiolog | 0.96127686 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.95310512 |
| 93 | MP0002938_white_spotting | 0.95107775 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.95037820 |
| 95 | MP0008874_decreased_physiological_sensi | 0.93929378 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 0.93425151 |
| 97 | * MP0003633_abnormal_nervous_system | 0.93336393 |
| 98 | MP0004885_abnormal_endolymph | 0.92849753 |
| 99 | * MP0003631_nervous_system_phenotype | 0.92490238 |
| 100 | MP0003121_genomic_imprinting | 0.89541766 |
| 101 | MP0002229_neurodegeneration | 0.88610371 |
| 102 | MP0003385_abnormal_body_wall | 0.88305163 |
| 103 | MP0003755_abnormal_palate_morphology | 0.86317637 |
| 104 | MP0002163_abnormal_gland_morphology | 0.85026642 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.84872885 |
| 106 | MP0003195_calcinosis | 0.84837263 |
| 107 | * MP0002152_abnormal_brain_morphology | 0.83970751 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.82381779 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.82053713 |
| 110 | MP0001664_abnormal_digestion | 0.81708429 |
| 111 | MP0003632_abnormal_nervous_system | 0.80071434 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.78471021 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.77621022 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.77405149 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.77112317 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.76321493 |
| 117 | MP0000747_muscle_weakness | 0.75640205 |
| 118 | MP0005171_absent_coat_pigmentation | 0.74937213 |
| 119 | MP0003879_abnormal_hair_cell | 0.74696130 |
| 120 | MP0004484_altered_response_of | 0.73777591 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.72913034 |
| 122 | MP0003941_abnormal_skin_development | 0.72780629 |
| 123 | MP0002233_abnormal_nose_morphology | 0.72703087 |
| 124 | MP0002127_abnormal_cardiovascular_syste | 0.72049029 |
| 125 | MP0003119_abnormal_digestive_system | 0.71398339 |
| 126 | MP0005275_abnormal_skin_tensile | 0.71207781 |
| 127 | MP0001943_abnormal_respiration | 0.69525385 |
| 128 | MP0008789_abnormal_olfactory_epithelium | 0.66270771 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.65912638 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.64035053 |
| 131 | MP0005187_abnormal_penis_morphology | 0.63575605 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.63013117 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.62942824 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.60287468 |
| 135 | MP0005620_abnormal_muscle_contractility | 0.59145917 |
| 136 | MP0005253_abnormal_eye_physiology | 0.56259477 |
| 137 | MP0003634_abnormal_glial_cell | 0.53572522 |
| 138 | MP0004272_abnormal_basement_membrane | 0.53562663 |
| 139 | MP0003787_abnormal_imprinting | 0.49610775 |
| 140 | MP0004084_abnormal_cardiac_muscle | 0.48430069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 8.00056022 |
| 2 | Limb dystonia (HP:0002451) | 7.23755289 |
| 3 | Focal motor seizures (HP:0011153) | 5.59309173 |
| 4 | Myokymia (HP:0002411) | 5.00010654 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.81112755 |
| 6 | Visual hallucinations (HP:0002367) | 4.55947892 |
| 7 | Focal seizures (HP:0007359) | 4.53825494 |
| 8 | Atonic seizures (HP:0010819) | 4.44723248 |
| 9 | Orthostatic hypotension (HP:0001278) | 3.99831897 |
| 10 | Pheochromocytoma (HP:0002666) | 3.85975896 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.78905429 |
| 12 | Febrile seizures (HP:0002373) | 3.62669078 |
| 13 | Absence seizures (HP:0002121) | 3.59910049 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.48085843 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.44255293 |
| 16 | Neuroendocrine neoplasm (HP:0100634) | 3.43076316 |
| 17 | Abnormal pupillary function (HP:0007686) | 3.31810633 |
| 18 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.29482557 |
| 19 | Action tremor (HP:0002345) | 3.23231174 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.19475402 |
| 21 | Epileptic encephalopathy (HP:0200134) | 3.18042777 |
| 22 | Dialeptic seizures (HP:0011146) | 3.17689330 |
| 23 | Amblyopia (HP:0000646) | 3.16583670 |
| 24 | Mitochondrial inheritance (HP:0001427) | 3.11942217 |
| 25 | Hypoventilation (HP:0002791) | 2.98257079 |
| 26 | Anxiety (HP:0000739) | 2.96336472 |
| 27 | Broad-based gait (HP:0002136) | 2.93620646 |
| 28 | Acute encephalopathy (HP:0006846) | 2.82508785 |
| 29 | Exotropia (HP:0000577) | 2.81333311 |
| 30 | Postural tremor (HP:0002174) | 2.79027502 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.73009892 |
| 32 | Truncal ataxia (HP:0002078) | 2.68248573 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.64987219 |
| 34 | Myotonia (HP:0002486) | 2.62253048 |
| 35 | Failure to thrive in infancy (HP:0001531) | 2.61793856 |
| 36 | Agitation (HP:0000713) | 2.59417999 |
| 37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.57243517 |
| 38 | Hypoplastic ischia (HP:0003175) | 2.51703927 |
| 39 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.50532251 |
| 40 | Broad metatarsal (HP:0001783) | 2.50294047 |
| 41 | Optic disc pallor (HP:0000543) | 2.42447200 |
| 42 | Cerebral hemorrhage (HP:0001342) | 2.41338246 |
| 43 | Dysmetria (HP:0001310) | 2.38942555 |
| 44 | Overgrowth (HP:0001548) | 2.37073138 |
| 45 | Increased CSF lactate (HP:0002490) | 2.34137048 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.33648379 |
| 47 | Abnormal pancreas size (HP:0012094) | 2.33259591 |
| 48 | Progressive inability to walk (HP:0002505) | 2.32869335 |
| 49 | Genital tract atresia (HP:0001827) | 2.32417627 |
| 50 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.32256811 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.31873985 |
| 52 | Abnormality of the corticospinal tract (HP:0002492) | 2.30738725 |
| 53 | Neonatal hypoglycemia (HP:0001998) | 2.30173948 |
| 54 | Hyperthyroidism (HP:0000836) | 2.26507335 |
| 55 | Popliteal pterygium (HP:0009756) | 2.22089864 |
| 56 | Abnormality of the ischium (HP:0003174) | 2.20624108 |
| 57 | Termporal pattern (HP:0011008) | 2.19921771 |
| 58 | Insidious onset (HP:0003587) | 2.19921771 |
| 59 | Hyperventilation (HP:0002883) | 2.19269427 |
| 60 | Depression (HP:0000716) | 2.18945051 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.18628641 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.16168279 |
| 63 | Facial shape deformation (HP:0011334) | 2.15753156 |
| 64 | Potter facies (HP:0002009) | 2.15753156 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.13890021 |
| 66 | Hemiparesis (HP:0001269) | 2.13579260 |
| 67 | Poor eye contact (HP:0000817) | 2.12343221 |
| 68 | Akinesia (HP:0002304) | 2.11775138 |
| 69 | Horizontal nystagmus (HP:0000666) | 2.11506684 |
| 70 | Gait imbalance (HP:0002141) | 2.11418587 |
| 71 | Increased hepatocellular lipid droplets (HP:0006565) | 2.11164381 |
| 72 | Vaginal atresia (HP:0000148) | 2.08578211 |
| 73 | Hypotension (HP:0002615) | 2.08299715 |
| 74 | Nephronophthisis (HP:0000090) | 2.07090094 |
| 75 | Delayed gross motor development (HP:0002194) | 2.05855290 |
| 76 | Scanning speech (HP:0002168) | 2.05698568 |
| 77 | Hepatocellular necrosis (HP:0001404) | 2.04359646 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 2.00589041 |
| 79 | Aortic aneurysm (HP:0004942) | 1.99218303 |
| 80 | Bundle branch block (HP:0011710) | 1.98515475 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 1.95948955 |
| 82 | Polyphagia (HP:0002591) | 1.94295372 |
| 83 | Abnormal social behavior (HP:0012433) | 1.93109107 |
| 84 | Impaired social interactions (HP:0000735) | 1.93109107 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92405285 |
| 86 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.92363541 |
| 87 | Hypoglycemic coma (HP:0001325) | 1.92126006 |
| 88 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.91934313 |
| 89 | Papilledema (HP:0001085) | 1.90563069 |
| 90 | Epileptiform EEG discharges (HP:0011182) | 1.90486128 |
| 91 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90141545 |
| 92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90141545 |
| 93 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.89532334 |
| 94 | Syncope (HP:0001279) | 1.89125458 |
| 95 | Bradykinesia (HP:0002067) | 1.89083017 |
| 96 | Psychosis (HP:0000709) | 1.88224042 |
| 97 | Aortic dissection (HP:0002647) | 1.86976704 |
| 98 | Genetic anticipation (HP:0003743) | 1.86304959 |
| 99 | Abnormal eating behavior (HP:0100738) | 1.85778787 |
| 100 | Hyperphosphatemia (HP:0002905) | 1.85640997 |
| 101 | Gait ataxia (HP:0002066) | 1.85420536 |
| 102 | Sudden death (HP:0001699) | 1.83665718 |
| 103 | Abnormality of the renal medulla (HP:0100957) | 1.83664489 |
| 104 | Autoamputation (HP:0001218) | 1.83648112 |
| 105 | Prolonged QT interval (HP:0001657) | 1.83548612 |
| 106 | Congenital primary aphakia (HP:0007707) | 1.83386894 |
| 107 | Abnormal ciliary motility (HP:0012262) | 1.82465848 |
| 108 | Cerebral edema (HP:0002181) | 1.82304880 |
| 109 | Diplopia (HP:0000651) | 1.81801164 |
| 110 | Abnormality of binocular vision (HP:0011514) | 1.81801164 |
| 111 | Emotional lability (HP:0000712) | 1.80840065 |
| 112 | Drooling (HP:0002307) | 1.80403361 |
| 113 | Excessive salivation (HP:0003781) | 1.80403361 |
| 114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.80005997 |
| 115 | Left ventricular hypertrophy (HP:0001712) | 1.79963448 |
| 116 | Renal Fanconi syndrome (HP:0001994) | 1.79573506 |
| 117 | Fetal akinesia sequence (HP:0001989) | 1.78556653 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78495932 |
| 119 | Esotropia (HP:0000565) | 1.78086207 |
| 120 | Bradycardia (HP:0001662) | 1.77853005 |
| 121 | Impaired smooth pursuit (HP:0007772) | 1.77318860 |
| 122 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.76912795 |
| 123 | Retinal dysplasia (HP:0007973) | 1.76813674 |
| 124 | X-linked dominant inheritance (HP:0001423) | 1.76463118 |
| 125 | Enlarged penis (HP:0000040) | 1.76084267 |
| 126 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76023409 |
| 127 | Rigidity (HP:0002063) | 1.75616157 |
| 128 | Ketoacidosis (HP:0001993) | 1.74034513 |
| 129 | True hermaphroditism (HP:0010459) | 1.72580107 |
| 130 | Abnormality of midbrain morphology (HP:0002418) | 1.72438195 |
| 131 | Molar tooth sign on MRI (HP:0002419) | 1.72438195 |
| 132 | Abnormality of the calf musculature (HP:0001430) | 1.72070071 |
| 133 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.71472845 |
| 134 | Tubular atrophy (HP:0000092) | 1.70668294 |
| 135 | Premature rupture of membranes (HP:0001788) | 1.70195460 |
| 136 | Metaphyseal dysplasia (HP:0100255) | 1.68620913 |
| 137 | Shawl scrotum (HP:0000049) | 1.68015042 |
| 138 | Large for gestational age (HP:0001520) | 1.67752571 |
| 139 | Hepatoblastoma (HP:0002884) | 1.67613509 |
| 140 | Neoplasm of the adrenal cortex (HP:0100641) | 1.65437127 |
| 141 | Cystic liver disease (HP:0006706) | 1.64547794 |
| 142 | Pancreatic cysts (HP:0001737) | 1.62939358 |
| 143 | Poor coordination (HP:0002370) | 1.62013356 |
| 144 | Increased number of teeth (HP:0011069) | 1.61904584 |
| 145 | Coronal craniosynostosis (HP:0004440) | 1.59909876 |
| 146 | Hyperglycemia (HP:0003074) | 1.59413350 |
| 147 | Occipital encephalocele (HP:0002085) | 1.59292272 |
| 148 | Rhinitis (HP:0012384) | 1.59205056 |
| 149 | Atrial fibrillation (HP:0005110) | 1.58328260 |
| 150 | Macroorchidism (HP:0000053) | 1.58060439 |
| 151 | Pulmonic stenosis (HP:0001642) | 1.57268918 |
| 152 | Limited hip movement (HP:0008800) | 1.56914245 |
| 153 | Abnormality of dentin (HP:0010299) | 1.56608793 |
| 154 | Congenital glaucoma (HP:0001087) | 1.56534789 |
| 155 | Buphthalmos (HP:0000557) | 1.55603405 |
| 156 | Disproportionate short-trunk short stature (HP:0003521) | 1.55256619 |
| 157 | Aqueductal stenosis (HP:0002410) | 1.55026821 |
| 158 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.54607558 |
| 159 | Absent/shortened dynein arms (HP:0200106) | 1.54607558 |
| 160 | Type II lissencephaly (HP:0007260) | 1.53290388 |
| 161 | Bowel diverticulosis (HP:0005222) | 1.53126218 |
| 162 | Hip contracture (HP:0003273) | 1.49989052 |
| 163 | Prominent supraorbital ridges (HP:0000336) | 1.49891015 |
| 164 | Absent speech (HP:0001344) | 1.49095409 |
| 165 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.49002853 |
| 166 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.49002853 |
| 167 | Hypomagnesemia (HP:0002917) | 1.45685845 |
| 168 | Arterial tortuosity (HP:0005116) | 1.44822537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.09074625 |
| 2 | PNCK | 3.97960132 |
| 3 | MAP3K12 | 3.78310224 |
| 4 | MAP3K4 | 3.75794974 |
| 5 | NTRK1 | 3.32732115 |
| 6 | GRK7 | 3.21416895 |
| 7 | MAP2K7 | 3.12401919 |
| 8 | NTRK3 | 3.03847099 |
| 9 | GRK5 | 2.89504617 |
| 10 | MAP2K4 | 2.58316435 |
| 11 | MAPKAPK5 | 2.54513393 |
| 12 | MAP3K9 | 2.51976044 |
| 13 | CASK | 2.29763621 |
| 14 | MINK1 | 2.18980605 |
| 15 | MARK1 | 1.96866010 |
| 16 | NTRK2 | 1.95710974 |
| 17 | STK38L | 1.66422763 |
| 18 | FGFR2 | 1.64927836 |
| 19 | PRKD3 | 1.59014791 |
| 20 | PLK2 | 1.54075375 |
| 21 | CSNK1G3 | 1.53226799 |
| 22 | CSNK1G2 | 1.51677717 |
| 23 | TNIK | 1.50668893 |
| 24 | PINK1 | 1.49195598 |
| 25 | LIMK1 | 1.48166538 |
| 26 | NME1 | 1.47658698 |
| 27 | STK39 | 1.43722923 |
| 28 | MYLK | 1.37315206 |
| 29 | ARAF | 1.31965844 |
| 30 | LATS1 | 1.30073064 |
| 31 | WNK1 | 1.29881607 |
| 32 | MET | 1.28231013 |
| 33 | CAMKK2 | 1.28229528 |
| 34 | ACVR1B | 1.26374897 |
| 35 | UHMK1 | 1.25758812 |
| 36 | WNK4 | 1.25103855 |
| 37 | MAPK13 | 1.23237251 |
| 38 | ADRBK1 | 1.23114279 |
| 39 | CAMK2A | 1.21693171 |
| 40 | GRK1 | 1.19248905 |
| 41 | TRPM7 | 1.16459172 |
| 42 | EPHA2 | 1.12613760 |
| 43 | PHKG1 | 1.11797269 |
| 44 | PHKG2 | 1.11797269 |
| 45 | CDK5 | 1.09994971 |
| 46 | CAMK2D | 1.09743401 |
| 47 | DAPK2 | 1.09578835 |
| 48 | DMPK | 1.07233741 |
| 49 | CAMK2B | 1.06400700 |
| 50 | CAMK1G | 1.03640560 |
| 51 | FGR | 1.03370623 |
| 52 | PIK3CA | 1.01159821 |
| 53 | MST1R | 1.00554483 |
| 54 | AKT3 | 1.00024123 |
| 55 | STK24 | 0.99681318 |
| 56 | CSNK1G1 | 0.98335997 |
| 57 | SIK2 | 0.97735352 |
| 58 | RET | 0.97467711 |
| 59 | STK16 | 0.96736046 |
| 60 | CDK19 | 0.96649941 |
| 61 | PRKCG | 0.95499489 |
| 62 | RIPK4 | 0.95283054 |
| 63 | EPHA4 | 0.93957044 |
| 64 | MATK | 0.93836945 |
| 65 | PTK2B | 0.93768158 |
| 66 | OXSR1 | 0.92813173 |
| 67 | ADRBK2 | 0.87871696 |
| 68 | PRKCE | 0.86749470 |
| 69 | CAMK2G | 0.82847235 |
| 70 | LATS2 | 0.82553044 |
| 71 | STK3 | 0.79290863 |
| 72 | TSSK6 | 0.78313243 |
| 73 | MAP2K1 | 0.77901848 |
| 74 | ERBB3 | 0.77512519 |
| 75 | ROCK1 | 0.77496949 |
| 76 | FES | 0.76714647 |
| 77 | MAP3K2 | 0.75818473 |
| 78 | GRK6 | 0.75028793 |
| 79 | KSR2 | 0.73840208 |
| 80 | PRKD2 | 0.73701774 |
| 81 | PAK2 | 0.72958214 |
| 82 | CDK14 | 0.72410674 |
| 83 | CAMK1D | 0.71828684 |
| 84 | CDK18 | 0.71612244 |
| 85 | CDK15 | 0.70277728 |
| 86 | MUSK | 0.70150565 |
| 87 | EPHB2 | 0.69508437 |
| 88 | PDGFRA | 0.68935217 |
| 89 | PRKAA1 | 0.68302121 |
| 90 | PAK6 | 0.68048476 |
| 91 | PAK3 | 0.66862737 |
| 92 | MKNK2 | 0.66833507 |
| 93 | MAP3K6 | 0.66669633 |
| 94 | INSRR | 0.65102476 |
| 95 | DYRK1A | 0.62993226 |
| 96 | BMPR1B | 0.62741013 |
| 97 | CDK11A | 0.61605856 |
| 98 | DAPK1 | 0.61248275 |
| 99 | SGK494 | 0.59292992 |
| 100 | SGK223 | 0.59292992 |
| 101 | SGK3 | 0.56463181 |
| 102 | ROCK2 | 0.55802167 |
| 103 | NUAK1 | 0.55229887 |
| 104 | CAMK1 | 0.54254960 |
| 105 | BCR | 0.53861566 |
| 106 | LMTK2 | 0.53493150 |
| 107 | MAPK15 | 0.53315919 |
| 108 | STK11 | 0.52960251 |
| 109 | PRKACA | 0.50309343 |
| 110 | MST4 | 0.50157953 |
| 111 | DDR2 | 0.49940911 |
| 112 | CAMKK1 | 0.49466790 |
| 113 | PRKAA2 | 0.48347661 |
| 114 | RPS6KA2 | 0.46395989 |
| 115 | FER | 0.45858549 |
| 116 | CSNK1E | 0.45632514 |
| 117 | PRKCZ | 0.45135925 |
| 118 | STK38 | 0.44330961 |
| 119 | WNK3 | 0.43086698 |
| 120 | BMPR2 | 0.42726220 |
| 121 | ERBB4 | 0.42356397 |
| 122 | ERBB2 | 0.40427187 |
| 123 | ILK | 0.39684770 |
| 124 | RIPK1 | 0.39666904 |
| 125 | SGK1 | 0.38573665 |
| 126 | PRKG1 | 0.37199007 |
| 127 | SIK3 | 0.36395551 |
| 128 | PRKCB | 0.36378601 |
| 129 | CDC42BPA | 0.34530772 |
| 130 | MAP3K13 | 0.34455017 |
| 131 | PRKCH | 0.33832643 |
| 132 | TIE1 | 0.33591875 |
| 133 | PTK2 | 0.32443346 |
| 134 | SGK2 | 0.32256649 |
| 135 | RPS6KA3 | 0.31775729 |
| 136 | KSR1 | 0.31411583 |
| 137 | PRKACB | 0.31301221 |
| 138 | PDK3 | 0.30857163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.66570749 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.47127527 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30939844 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.17334421 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.91922590 |
| 6 | Cocaine addiction_Homo sapiens_hsa05030 | 2.83371625 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.60946512 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.52530537 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.40859003 |
| 10 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39962274 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.30248951 |
| 12 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29213487 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.14368078 |
| 14 | * Serotonergic synapse_Homo sapiens_hsa04726 | 2.14199525 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.09495351 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.99047756 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.94186552 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92702189 |
| 19 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.91294292 |
| 20 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.90809946 |
| 21 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.90583409 |
| 22 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.86888949 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.86275012 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.81961099 |
| 25 | * Long-term potentiation_Homo sapiens_hsa04720 | 1.79163503 |
| 26 | * Long-term depression_Homo sapiens_hsa04730 | 1.64101176 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.57099184 |
| 28 | * Salivary secretion_Homo sapiens_hsa04970 | 1.56211715 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53012139 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.51874758 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51850049 |
| 32 | * Renin secretion_Homo sapiens_hsa04924 | 1.48980870 |
| 33 | * Insulin secretion_Homo sapiens_hsa04911 | 1.48445608 |
| 34 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38736739 |
| 35 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28793365 |
| 36 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.27406990 |
| 37 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24869285 |
| 38 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22511281 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.21478453 |
| 40 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17741692 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.17246336 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.17048981 |
| 43 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14267915 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11967818 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.11468811 |
| 46 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.10981045 |
| 47 | * Gap junction_Homo sapiens_hsa04540 | 1.08959627 |
| 48 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06746537 |
| 49 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.06602559 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00608174 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00022711 |
| 52 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91593441 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90670397 |
| 54 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.88857914 |
| 55 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88845554 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85944462 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85756473 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85556173 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82388009 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.81689804 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.80614489 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79220659 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78916764 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78886535 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.78555068 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.78352563 |
| 67 | Melanoma_Homo sapiens_hsa05218 | 0.77632291 |
| 68 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76603969 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74484191 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72806763 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.72425218 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.71320022 |
| 73 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71317729 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70114758 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69681425 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69417483 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68763262 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.68092567 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67878160 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67332239 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65312955 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64645312 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64602101 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63800498 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62307583 |
| 86 | * Melanogenesis_Homo sapiens_hsa04916 | 0.61598871 |
| 87 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59482614 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58062768 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55440463 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54636464 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54327168 |
| 92 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52686362 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52535666 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51946318 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50499933 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49500021 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48744371 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48008308 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47553766 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47313688 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46968477 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46579418 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45256303 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44764568 |
| 105 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44484595 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43546924 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43152223 |
| 108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43035557 |
| 109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42520598 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39659783 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.39354511 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39074946 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38455428 |
| 114 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37394592 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.37207184 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.37096911 |
| 117 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35834535 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35804919 |
| 119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34434741 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29382860 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29046713 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.26903630 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25677669 |
| 124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23593095 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21017225 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21008348 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20585130 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20246361 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18799692 |
| 130 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18376899 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18137606 |
| 132 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16503696 |
| 133 | Proteasome_Homo sapiens_hsa03050 | 0.15802349 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14557142 |
| 135 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.14476129 |
| 136 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.11283182 |
| 137 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.09665818 |

